Félix Guerrero‐Ramos

Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression

Cristina Segovia, Edurne San José‐Eneriz, Ester Munera-Maravilla et al. · Nature Medicine · 2019 · 191 citations

Medicine, Immunology, Oncology +10

Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial

Neal D. Shore, Thomas Powles, Jens Bedke et al. · Nature Medicine · 2025 · 74 citations · Full text

Medicine, Oncology, Urology +16

Kidney transplant from uncontrolled donation after circulatory death donors maintained by nECMO has long-term outcomes comparable to standard criteria donation after brain death

María Molina, Félix Guerrero‐Ramos, Mario Fernández‐Ruiz et al. · American Journal of Transplantation · 2018 · 61 citations

Medicine, Surgery, Kidney Transplantation +9

Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial

Félix Guerrero‐Ramos, Daniel A. González‐Padilla, Alejandro González-Díaz et al. · World Journal of Urology · 2022 · 61 citations · Full text

Medicine, Oncology, Urology +13

CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of <i>RB1</i> Status

Carolina Rubio, Mónica Martínez‐Fernández, Cristina Segovia et al. · Clinical Cancer Research · 2018 · 59 citations

Medicine, Oncology, Pharmacology +14